-+ 0.00%
-+ 0.00%
-+ 0.00%

Wedbush Reiterates Outperform on Jade Biosciences, Maintains $47 Price Target

Benzinga·10/01/2026 12:27:37
语音播报
Wedbush analyst Laura Chico reiterates Jade Biosciences (NASDAQ:JBIO) with a Outperform and maintains $47 price target.